5-HT3 antagonist 3

CAS No. 120635-47-4

5-HT3 antagonist 3 ( —— )

Catalog No. M26032 CAS No. 120635-47-4

5-HT3 antagonist 3 (Compound 15b) is a high-affinity 5-HT3 receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 264 Get Quote
5MG 404 Get Quote
10MG 593 Get Quote
25MG 888 Get Quote
50MG 1251 Get Quote
100MG 1692 Get Quote
500MG 3402 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    5-HT3 antagonist 3
  • Note
    Research use only, not for human use.
  • Brief Description
    5-HT3 antagonist 3 (Compound 15b) is a high-affinity 5-HT3 receptor antagonist.
  • Description
    5-HT3 antagonist 3 (Compound 15b) is a high-affinity 5-HT3 receptor antagonist. It binds to 5-HT3 receptors in rat brain cortical membranes (Ki: 0.25 nM).(In Vitro):Serotonin (5-HT), involved in numerous physiological and pathophysiological processes, interacts with various distinct membrane receptors.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    β1 integrin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    120635-47-4
  • Formula Weight
    319.4
  • Molecular Formula
    C20H21N3O
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1nccn1CC1CCc2c(C1=O)c1cccc3CCCn2c13
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shah BS, et al. Pyrintegrin Induces Soft Tissue Formation by Transplanted or Endogenous Cells. Sci Rep. 2017 Jan 27;7:36402.
molnova catalog
related products
  • SB 737050A

    SB 737050A is a potent, selective 5-HT6 receptor antagonist to prevent relapse intio addiction.

  • Lerisetron

    Lerisetron is an antagonist of serotonin type 3 (5-HT3) receptor, with antiemetic activity.

  • DREADD agonist 21

    DREADD agonist 21 is a potent agonist of human muscarinic acetylcholine M3 receptors (EC50=1.7 nM).